Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02536300
Title Dose Optimization Study of Idelalisib in Follicular Lymphoma
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Gilead Sciences
Indications
Therapies
Age Groups: senior | adult
Covered Countries ITA | FRA | ESP | CAN


No variant requirements are available.